Common Contracts
2 similar Securities Purchase Agreement contracts by Akero Therapeutics, Inc., Kura Oncology, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 3rd, 2022 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 2, 2022, between Kura Oncology, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Bristol-Myers Squibb Company, a corporation organized under the laws of the State of Delaware (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • Akero Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 15, 2022, between Akero Therapeutics, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and Pfizer Inc., a corporation organized under the laws of the State of Delaware (the “Purchaser”).
